RSCM
Rock Springs Capital Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-206,108
| Closed | -$10.9M | – | 111 |
|
|
2024
Q3 | $10.9M | Buy |
+206,108
| New | +$10.9M | 0.35% | 65 |
|
|
2023
Q4 | – | Sell |
-134,252
| Closed | -$3.96M | – | 106 |
|
|
2023
Q3 | $3.96M | Sell |
134,252
-313,348
| -70% | -$9.23M | 0.11% | 87 |
|
|
2023
Q2 | $14.6M | Hold |
447,600
| – | – | 0.35% | 66 |
|
|
2023
Q1 | $15.8M | Buy |
447,600
+4,600
| +1% | +$162K | 0.38% | 65 |
|
|
2022
Q4 | $20.3M | Hold |
443,000
| – | – | 0.49% | 56 |
|
|
2022
Q3 | $21.5M | Buy |
443,000
+43,000
| +11% | +$2.08M | 0.55% | 53 |
|
|
2022
Q2 | $15.7M | Buy |
+400,000
| New | +$15.7M | 0.46% | 59 |
|
|
2020
Q4 | – | Sell |
-206,495
| Closed | -$4.47M | – | 157 |
|
|
2020
Q3 | $4.47M | Buy |
206,495
+129,078
| +167% | +$2.79M | 0.11% | 133 |
|
|
2020
Q2 | $1.83M | Buy |
+77,417
| New | +$1.83M | 0.05% | 136 |
|